In 2018, the American Gastroenterological Association's Center for GI Innovation and Technology convened a consensus conference, entitled “Colorectal Cancer Screening and Surveillance: Role of Emerging Technology and Innovation to Improve Outcomes.” The conference participants, which included more than 60 experts in colorectal cancer, considered recent improvements in colorectal cancer screening rates and polyp detection, persistent barriers to colonoscopy uptake, and opportunities for performance improvement and innovation. This white paper originates from that conference. It aims to summarize current patient- and physician-centered gaps and challenges in colonoscopy, diagnostic and therapeutic challenges affecting colonoscopy uptake, and the potential use of emerging technologies and quality metrics to improve patient outcomes.
Bibliographical noteFunding Information:
Conflicts of interest These authors disclose the following: Srinadh Komanduri has received consulting fees from Boston Scientific Corporation and Medtronic. Uri Ladabaum has received consulting fees from Clinical Genomics, Medtronic, Motus GI, and Quorum; has received research support from Exact Sciences; and served on the advisory board of Universal Dx. Michael F. Byrne has affiliations with ai4gi, Satis Operations, Inc, and Olympus America. Heiko Pohl has received research support from Cosmo and Steris. V. Raman Muthusamy has received consulting fees from Boston Scientific Corporation, Interpace Diagnostics, Medtronic, and Medivators; has received speaking fees from Torax Medical Inc; and has received research support from Medtronic and Boston Scientific . The remaining authors disclose no conflicts.
© 2022 AGA Institute
- Adenoma Detection Rate (ADR)
- Artificial Intelligence (AI)
- Colorectal Cancer (CRC)
- Polyp Detection